Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erythropoietin: the developing story.

Literature DB >> 3130919

Erythropoietin: the developing story.

P M Cotes¹.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 1988 PMID： 3130919 PMCID： PMC2545097 DOI： 10.1136/bmj.296.6625.805

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

35 in total

1. Evidence for a humoral regulation of erythropoiesis; studies on a patient with polycythemia secondary to regional hypoxia.

Authors: F STOHLMAN; C E RATH; J C ROSE
Journal: Blood Date: 1954-07 Impact factor: 22.113

2. Humoral regulation of red cell production.

Authors: A ERSLEV
Journal: Blood Date: 1953-04 Impact factor: 22.113

3. Purification of human erythropoietin.

Authors: T Miyake; C K Kung; E Goldwasser
Journal: J Biol Chem Date: 1977-08-10 Impact factor: 5.157

4. Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates.

Authors: P M Cotes
Journal: Br J Haematol Date: 1982-03 Impact factor: 6.998

5. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].

Authors: B Stutz; K Rhyner; J Vögtli; U Binswanger
Journal: Schweiz Med Wochenschr Date: 1987-09-19

6. Characterization and biological effects of recombinant human erythropoietin.

Authors: J C Egrie; T W Strickland; J Lane; K Aoki; A M Cohen; R Smalling; G Trail; F K Lin; J K Browne; D K Hines
Journal: Immunobiology Date: 1986-09 Impact factor: 3.144

7. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.

Authors: J W Eschbach; J Mladenovic; J F Garcia; P W Wahl; J W Adamson
Journal: J Clin Invest Date: 1984-08 Impact factor: 14.808

8. Human erythropoietin stimulates murine megakaryopoiesis in serum-free culture.

Authors: M Sakaguchi; M Kawakita; J Matsushita; K Shibuya; Y Koishihara; K Takatsuki
Journal: Exp Hematol Date: 1987-11 Impact factor: 3.084

9. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

Authors: C G Winearls; D O Oliver; M J Pippard; C Reid; M R Downing; P M Cotes
Journal: Lancet Date: 1986-11-22 Impact factor: 79.321

Erythropoietin: the developing story.

1. Evidence for a humoral regulation of erythropoiesis; studies on a patient with polycythemia secondary to regional hypoxia.

2. Humoral regulation of red cell production.

3. Purification of human erythropoietin.

4. Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates.

5. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].

6. Characterization and biological effects of recombinant human erythropoietin.

7. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.

8. Human erythropoietin stimulates murine megakaryopoiesis in serum-free culture.

9. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

10. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.

1. Neonatology--then and now. Anaemia of prematurity (1962).

Review 2. Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment.

Review 3. The role of erythropoietin in the anaemia of chronic disease in rheumatoid arthritis.

Review 4. The Influence of Inflammation on Anemia in CKD Patients.